Juraj Michalec

Mr. Juraj Michalec

Medical student

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 November 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
JBJan Broz
Jan Broz
MCMatthew D. Campbell
Matthew D. Campbell
JUJana Urbanová
Jana Urbanová
MNMarisa Nunes
Marisa Nunes
LBLudmila Brunerová
Ludmila Brunerová
JPJan Polák
Jan Polák
The glycemic response to ingested glucose for the treatment of hypoglycemia following exercise in type 1 diabetes patients has never been studied. Therefore, we aimed to characterize glucose dynamics during a standardized bout of hypoglycemia-inducing exercise and the subsequent hypoglycemia treatment with the oral ingestion of glucose. Ten male patients with type 1 diabetes performed a standardized bout of cycling exercise using an electrically braked ergometer at a target heart rate (THR) of 50% of the individual heart rate reserve, determined using the Karvonen equation. Exercise was terminated when hypoglycemia was reached, followed by immediate hypoglycemia treatment with the oral ingestion of 20 g of glucose. Arterialized blood glucose (ABG) levels were monitored at 5 min intervals during exercise and for 60 min during recovery. During exercise, ABG decreased at a mean rate of 0.11 ± 0.03 mmol/L·min−1 (minimum: 0.07, maximum: 0.17 mmol/L·min−1). During recovery, ABG increased at a mean rate of 0.13 ± 0.05 mmol/L·min−1 (minimum: 0.06, maximum: 0.19 mmol/L·min−1). Moreover, 20 g of glucose maintained recovery from hypoglycemia throughout the 60 min postexercise observation window.

4 July 2023 in Epilepsia Open
Verified
Journal Article
Open access
KBKlára Brožová
Klára Brožová
Juraj MichalecJuraj Michalec
Juraj Michalec
MBMarek Brabec
Marek Brabec
PBPetra Bořilová
Petra Bořilová
PKPavel Kohout
Pavel Kohout
JBJan Broz
Jan Broz
Objective: The ketogenic diet (KD) is a diet low in carbohydrates and rich in fats which has long been used to treat refractory epilepsy. The metabolic changes related to the KD may increase the risk of hypoglycemia, especially during the first days. The study focused on the impact of KD initiation on glycemia in non‐diabetic patients with refractory epilepsy.Methods: The subjects were 10 pediatric patients (6 boys, mean age 6.1 ± 2.4 years), treated for intractable epilepsy. Blinded continuous glucose monitoring system (CGM) Dexcom G4 was used. Patients started on their regular diet in the first 36 hours of monitoring, followed by an increase in lipids intake and a gradual reduction of carbohydrates (relations 1:1; 2:1; 3:1; 3.5:1). We analyzed changes in glycemia during fat: nonfat ratio changes using a generalized linear model.Results: The mean monitored time per person was 6 days, 10 hours and 44 minutes. The mean ± SD glycemia for the regular diet was 4.84 ± 0.20 mmol/L, for the carbohydrates/fat ratio of 1:1 it was 4.03 ± 0.16, for the ratio of 2:1 it was 3.57 ± 0.10, for the ratio 3:1 it was 3.39 ± 0.13 and for the final ratio of 3.5:1 it was 2.79 ± 0.06 mmol/L (P < 0.001). The portions of time spent in glycemia ≤3.5 mmol/L (≤2.5 mmol/L respectively) were: on the normal diet 0.88% (0.31%) of the monitored period, during 1:1 KD ratio 1.92% (0.95%), during 2:1 ratio 3.18% (1.02%), and during 3:1 and 3.5:1 ratios 13.64% (2.36%) of the monitored time (P < 0.05).Significance: Continuous glucose monitoring system shows the dynamic of glucose concentration in ketogenic diet treatment initiation. It may be a useful tool to control the effects of this diet on glucose metabolism, especially in hypoglycemia detection.

18 September 2023 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
JBJan Broz
Jan Broz
MCMatthew D. Campbell
Matthew D. Campbell
PKPavlína Krollová
Pavlína Krollová
Juraj MichalecJuraj Michalec
Juraj Michalec


2 May 2023 in JMIR Preprints
Verified
Preprint
Open access
JBJan Broz
Jan Broz
MCMatthew D. Campbell
Matthew D. Campbell
PKPavlína Krollová
Pavlína Krollová
Juraj MichalecJuraj Michalec
Juraj Michalec
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

16 September 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Juraj MichalecJuraj Michalec
Juraj Michalec
MLMichala Lustigova
Michala Lustigova
AFAnna Frűhaufová
Anna Frűhaufová
ŠMŠárka Malá
Šárka Malá
PKPavlína Krollová
Pavlína Krollová
JBJan Brož
Jan Brož
Introduction: Cardiovascular events are still the most common cause of death in the Czech Republic. The increasing prevalence of risk factors such as dyslipidaemia, hypertension, obesity, and diabetes individually and collectively contribute to cardiovascular events. The aim of this study was to determine their prevalence and interrelationships. Method: The data for this epidemiological study were obtained from the Czech cross-sectional study EHES 2019 (European Health Examination Survey) with stratified random sampling. Firstly, individual risk factors (dyslipidaemia, hypertension, obesity, diabetes, and smoking) in population aged 25–64 years of age were monitored using questionnaires and physical and laboratory measurements; additionally, the cumulative effect of these risk factors in subjects was examined. Finally, cardiovascular risk in the age group of 40–64 years (767 out of 1057 participants) was estimated using the SCORE EU chart (for countries with high cardiovascular risk). Individual parameters were assessed according to standard criteria: dyslipidaemia = total cholesterol ≥5.0 mmol/l, and/or HDL-C < 1.0 mmol/l in men, or 30 kg/m2; hypertension = systolic blood pressure ≥ 140 mmHg, and/or diastolic blood pressure ≥ 90 mmHg, and/or antihypertensive treatment; diabetes mellitus = HbA1c ≥ 48 mmol/mol and/or on treatment. Data were analysed by descriptive statistics. Results: Of the total number of 1057 study participants (426 men and 631 women) aged 25–64 years, roughly 84% presented with ≥1 cardiovascular disease risk factor. The most common risk factor was dyslipidaemia, which occurred in 71.7% of the subjects. The prevalence of hypertension was 36.3% (men 46.0%, women 26.3%). 29.7% of subjects were obese, diabetes mellitus occurred in 5.7% (men 7.6%, women 3.7%). 17.7% were regular smokers; another 6.6% reported occasional smoking. A combination of risk factors was common, e.g., 77.3% had dyslipidaemia and/or hypertension. There were 16.1% of subjects without monitored cardiovascular risk factors. After stratification of cardiovascular risk prediction according to SCORE chart, 49.7% of individuals fall into low risk, 28.6% into medium risk, and up to 11.3% into high and 10.4% into very high risk. Conclusion: The most common risk factor is lipid spectrum disorders (71.7%). Combination of risk factors is common, which increases the risk of cardiovascular events in these individuals. In the 40–64 age group, 21.7% of the population is at >5% risk of a fatal cardiovascular event over the next 10 years.